FDA Warning Letter — BioLyte Laboratories, LLC
The FDA took a Warning Letter action against BioLyte Laboratories, LLC on Mar 18, 2021 (Grand Rapids, MI). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- BioLyte Laboratories, LLC
- Date
- Mar 18, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Center
- CDER
- Location
- Grand Rapids, MI (United States)